What is the role of pharmaceutical benefit managers (PBMs)?

Pharmaceutical benefit managers (PBMs) serve as intermediaries between drug manufacturers, pharmacies, and insurers, managing prescription drug benefits for health plans. Their role includes negotiating drug prices, forming pharmacy networks, and processing claims. By managing formularies, promoting the use of cost-effective generics, and implementing disease management programmes, PBMs help control drug costs while ensuring patients have access to necessary medications.

How do PBMs negotiate drug pricing?

PBMs negotiate drug pricing by leveraging their purchasing power to secure discounts and rebates from pharmaceutical manufacturers. These negotiations often involve complex agreements that can significantly lower the cost of medications for health plans. PBMs also use formulary management to prioritise cost-effective therapies.

What services do PBMs offer to pharmaceutical companies?

PBMs offer services like formulary management, claims processing, rebate negotiation, and compliance support for pharmaceutical companies. They provide data analytics and health intelligence, which helps drug manufacturers optimise pricing strategies and gain insights into market access trends. PBMs also facilitate patient access to new therapies through innovative value-based contracts.

How do PBMs impact patient care?

PBMs improve patient care by enhancing medication adherence through clinical support programmes, promoting the use of generics and affordable medications, and providing resources for disease management. They also help streamline the approval process for necessary treatments, ensuring timely access to medications. By reducing costs and improving access, PBMs help patients better manage chronic conditions.

What are the challenges faced by PBMs in the pharmaceutical industry?

PBMs face challenges like increasing regulatory scrutiny, the need for greater transparency in pricing practices, and the rising cost of specialty drugs. As healthcare costs continue to rise, PBMs must balance their role in cost containment with ensuring that patients receive high-quality care. Additionally, there is growing pressure for PBMs to demonstrate the value they provide in the drug supply chain.

Pharmaceutical Benefit Managers and Management

Buyer's Guides

Pharmacy Benefit Management Companies for the Pharmaceutical Industry

News

MHRA consults public on reclassification of codeine linctus

Features

Insulin pricing in flux as major pharma players take action

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Pharmacy Benefit Management Companies for the Pharmaceutical Industry

MHRA consults public on reclassification of codeine linctus

Insulin pricing in flux as major pharma players take action

Leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry

Leading account and intent-based sales and marketing providers and technology solutions for the pharmaceutical industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief